Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 1010.48 | 96 |
GSM780708 | Untreated after 4 days (C2_1) | 808.254 | 95 |
GSM780709 | Untreated after 4 days (C3_1) | 914.601 | 95 |
GSM780719 | Untreated after 4 days (C1_2) | 1045.4 | 96 |
GSM780720 | Untreated after 4 days (C2_2) | 879.985 | 95 |
GSM780721 | Untreated after 4 days (C3_2) | 965.556 | 95 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 667.268 | 93 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1002.29 | 96 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 773.874 | 94 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 735.163 | 94 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1033.48 | 96 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 792.878 | 94 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1031.71 | 96 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 744.861 | 94 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 947.628 | 95 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1186.8 | 96 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 828.211 | 95 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1013.47 | 96 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 990.603 | 96 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1036.14 | 96 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 798.162 | 94 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1035.8 | 96 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 917.008 | 95 |